At 4.5% CAGR, the North America Nanoparticle Measurement Instrument Market is Projected to be Worth US$ 5,072.73 Million by 2031, Says Business Market Insights

According to Business Market Insights' research, the North America nanoparticle measurement instrument market was valued at US$ 3,567.46 million in 2023 and is expected to reach US$ 5,072.73 million by 2031, registering a CAGR of 4.5% from 2023 to 2031. Increasing applications of nanotechnology and advancements in analytical techniques are among the critical factors attributed to the North America nanoparticle measurement instrument market expansion.

Nanotechnology is being employed in a rising number of applications in the pharmaceutical industry, including cancer treatment, targeted drug delivery, and diagnostic imaging. The use of nanoparticles as drug delivery vehicles helps increase efficiency and lower the side effects of therapeutic candidates. Nanopharmaceuticals are the materials manipulated at the nanoscale, often to produce drugs with enhanced bioavailability, controlled release properties, or targeting. These applications need precise measuring devices to monitor drug delivery, assure quality control, and characterize nanoparticles. A thorough understanding of and control over nanoparticle size, shape, surface charge, and composition are necessary to develop nanopharmaceuticals. Thus, zeta potential analyzers, electron microscopes, and size analyzers are essential for investigations related to nanoparticles. Thus, the ongoing research in nanotechnology results in the need for more sophisticated and precise measurement tools. Nanopharmaceuticals can ensure the precise delivery of drugs to particular tissues or cells, along with improving their stability and solubility. The continuous research and optimization efforts in the field of nanotechnology depend on the availability of sophisticated measurement tools to understand and alter the interactions and properties at the nanoscale.

fb-PMT, the first clinical candidate from NanoPharmaceuticals, an emerging, clinical stage pharmaceutical company. A Phase I clinical trial for fb-PMT in GBM patients is underway at Yale Cancer Center, which would be followed by the Phase II trials involving patients with glioblastoma, pancreatic cancer, and AML.

In October 2022, Mikart LLC, a comprehensive contract development and manufacturing organization, announced the collaboration agreement with Nano PharmaSolutions, Inc. This collaboration provides GMP manufacturing capabilities for the development of nanomedicines using our NanoTransformer technology at Mikart's facility

The drive for innovation in the pharmaceutical sector through nanotechnology boosts the need for sophisticated nanopharmaceutical measurement tools. These tools are crucial for the development, characterization, and quality assurance of nanopharmaceuticals, ensuring that they adhere to strict safety, efficacy, and regulatory compliance specifications.

On the contrary, high cost of instruments hampers the growth of North America nanoparticle measurement instrument market.

Based on type, the North America nanoparticle measurement instrument market is segmented into X-Ray diffractometer, scanning electron microscope, atomic force microscope, photon correlation spectroscopy, nanoparticle surface area monitor, transmission electron microscope, condensation particle counter, differential mobility analyzer, scanning mobility particle sizer, nanoparticle tracking analyzer, aerosol particle mass analyzer, and others. The transmission electron microscope segment held 21.6% share of the North America nanoparticle measurement instrument market in 2023, amassing US$ 770.83 million. It is projected to garner US$ 1,146.25 million by 2031 to expand at 5.1% CAGR during 2023–2031.

Based on end user, the North America nanoparticle measurement instrument market is segmented into biotechnology industry, pharmaceutical industry, contract research organizations (CROs), and others. The pharmaceutical industry segment held 38.0% share of the North America nanoparticle measurement instrument market in 2023, amassing US$ 1,355.07 million. It is projected to garner US$ 1,984.01 million by 2031 to expand at 4.9% CAGR during 2023–2031.

Based on country, the North America nanoparticle measurement instrument market is segmented into the US, Canada, and Mexico. The US held 90.6% share of North America nanoparticle measurement instrument market in 2023, amassing US$ 3,230.33 million. It is projected to garner US$ 4,615.17 million by 2031 to expand at 4.6% CAGR during 2023–2031.

Key players operating in the nanoparticle measurement instrument market are Bruker; Spectradyne LLC.; Malvern Panalytical Ltd; IZON Science LTD; Particle Metrix GmbH; Microtrac Retsch GmbH; Horiba Ltd; Angstrom Advanced Inc.; Shimadzu Corp; and Yokogawa Electric Corp, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com